BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22609204)

  • 1. Wnt5a signaling is a substantial constituent in bone morphogenetic protein-2-mediated osteoblastogenesis.
    Nemoto E; Ebe Y; Kanaya S; Tsuchiya M; Nakamura T; Tamura M; Shimauchi H
    Biochem Biophys Res Commun; 2012 Jun; 422(4):627-32. PubMed ID: 22609204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y; Rubin B; Bodine PV; Billiard J
    J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
    Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
    J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
    Nakashima A; Katagiri T; Tamura M
    J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification.
    Xin H; Xin F; Zhou S; Guan S
    Int J Mol Med; 2013 Mar; 31(3):583-8. PubMed ID: 23337931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.
    Sonomoto K; Yamaoka K; Oshita K; Fukuyo S; Zhang X; Nakano K; Okada Y; Tanaka Y
    Arthritis Rheum; 2012 Oct; 64(10):3355-63. PubMed ID: 22674197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
    Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
    J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
    Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism.
    Li J; Khavandgar Z; Lin SH; Murshed M
    Bone; 2011 Feb; 48(2):321-31. PubMed ID: 20932949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
    Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y
    Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways.
    Park KH; Kang JW; Lee EM; Kim JS; Rhee YH; Kim M; Jeong SJ; Park YG; Kim SH
    J Pineal Res; 2011 Sep; 51(2):187-94. PubMed ID: 21470302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a/Ror2 mediates temporomandibular joint subchondral bone remodeling.
    Yang T; Zhang J; Cao Y; Zhang M; Jing L; Jiao K; Yu S; Chang W; Chen D; Wang M
    J Dent Res; 2015 Jun; 94(6):803-12. PubMed ID: 25749876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
    Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
    Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
    Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T
    J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.